Furthermore, by down-regulating the TGF-β1-dependent pro-fibrotic signaling pathway in HN mice, tubulointerstitial fibrosis is inhibited and the transition from AKI to CKD is delayed. This evidence concerns the gene TGFB1 and chronic kidney disease.